Medtronic Earns CE Mark For Affera Ablation System, Touts New PFA Results

 
• By Reed Miller

Results of the PULSED AF trial confirm that Medtronic’s PulseSelect pulsed field ablation is safe and effective for atrial fibrillation ablation. The company will likely incorporate PulseSelect into its Affera cardiac mapping and ablation system, which will soon be available in Europe.

Atrial fibrillation and normal or abnormal heart rate rythm as a cardiac disorder as a human organ with healthy and unhealthy ecg monitoring in a 3D illustration style.
• Source: Shutterstock

More from Approvals

More from Policy & Regulation